Max R Langham
Overview
Explore the profile of Max R Langham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fleming A, Gehle D, Freitas J, Hendrick L, Yakoub D, Abdelhafeez H, et al.
J Surg Oncol
. 2024 Aug;
130(5):1051-1061.
PMID: 39155692
Background And Objectives: Solid pseudopapillary neoplasm (SPN) of the pancreas demonstrates an indolent disease course; however, some patients present with a "malignant" phenotype, including distant metastases resistant to chemotherapy. This...
2.
Kastenberg Z, Short S, Riehle K, Utria A, Lautz T, Ott K, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(6):e30975.
PMID: 38556718
Background: Undifferentiated embryonal sarcoma of the liver (UESL) is a rare tumor for which there are few evidence-based guidelines. The aim of this study was to define current management strategies...
3.
Kastenberg Z, Baertschiger R, Cuenca A, Galvan N, Lemoine C, Roach J, et al.
Semin Pediatr Surg
. 2023 Nov;
32(5):151340.
PMID: 38008042
The appropriate management of pediatric liver malignancies, primarily hepatoblastoma and hepatocellular carcinoma, requires an in depth understanding of contemporary preoperative risk stratification, experience with advanced hepatobiliary surgery, and a good...
4.
Thompson P, Malogolowkin M, Furman W, Piao J, Krailo M, Chung N, et al.
Pediatr Blood Cancer
. 2023 Apr;
70(7):e30365.
PMID: 37073741
Background: Survival for children with metastatic hepatoblastoma (HB) remains suboptimal. We report the response rate and outcome of two courses of vincristine/irinotecan/temsirolimus (VIT) in children with high-risk (HR)/metastatic HB. Procedures:...
5.
Vasudevan S, Meyers R, Finegold M, Lopez-Terrada D, Ranganathan S, Dunn S, et al.
J Pediatr Surg
. 2022 Jul;
57(10):251-256.
PMID: 35810020
Background: Hepatoblastoma (HB) requires surgical resection for cure, but only 20-30% of patients have resectable disease at diagnosis. Patients who undergo partial hepatectomy at diagnosis have historically received 4-6 cycles...
6.
Fleming A, Duffy C, Gartrell J, McCarville M, Langham M, Ruiz R, et al.
J Surg Case Rep
. 2022 Jun;
2022(5):rjac238.
PMID: 35665385
Giant focal nodular hyperplasia (GFNH) is rarely seen in children, presenting complex diagnostic and management considerations. Pathognomonic radiographic findings can be absent in this population, and the nuances of pathologic...
7.
Short S, Kastenberg Z, Wei G, Bondoc A, Dasgupta R, Tiao G, et al.
Cancer
. 2022 May;
128(14):2786-2795.
PMID: 35561331
Background: Hepatocellular carcinoma (HCC) is a rare cancer in children, with various histologic subtypes and a paucity of data to guide clinical management and predict prognosis. Methods: A multi-institutional review...
8.
Trobaugh-Lotrario A, Katzenstein H, Ranganathan S, Lopez-Terrada D, Krailo M, Piao J, et al.
J Clin Oncol
. 2021 Dec;
40(5):459-467.
PMID: 34874751
Purpose: Small cell undifferentiated (SCU) histology in hepatoblastoma (HB) tumors has historically been associated with a poor prognosis. Tumors from patients enrolled on Children's Oncology Group (COG) study AHEP0731 underwent...
9.
Katzenstein H, Malogolowkin M, Krailo M, Piao J, Towbin A, McCarville M, et al.
Cancer
. 2021 Nov;
128(5):1057-1065.
PMID: 34762296
Background: The Children's Oncology Group (COG) adopted cisplatin, 5-flourouracil, and vincristine (C5V) as standard therapy after the INT-0098 legacy study showed statistically equivalent survival but less toxicity in comparison with...
10.
Sutthatarn P, Morin C, Gartrell J, Furman W, Langham M, Santiago T, et al.
Children (Basel)
. 2021 Apr;
8(3).
PMID: 33809687
Pulmonary ossification (PO) is a rare finding, characterized by mature bone formation in the lung parenchyma. We report a 20-year-old female patient diagnosed with fibrolamellar hepatocellular carcinoma (FL-HCC) and bilateral...